A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer

Por Marcuello, E, Páez, D, Paré, L, Salazar, J, Sebio, A, del Rio, E, Baiget, M
Publicado em 2011

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

Por Paré, L, Marcuello, E, Altés, A, Río, E del, Sedano, L, Salazar, J, Cortés, A, Barnadas, A, Baiget, M
Publicado em 2008

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

Por Paré, L, Marcuello, E, Altés, A, del Río, E, Sedano, L, Salazar, J, Cortés, A, Barnadas, A, Baiget, M
Publicado em 2009